RENOVARO INC. - COMMON STOCK

Enochian BioSciences Announces that its Cancer Platform Remains on Track for Trials in Humans Following FDA Review

08 Jun 2023 08:45:00 By Nasdaq GlobeNewswire

Enochian BioSciences’ CEO Letter to Shareholders

03 Apr 2023 09:00:00 By Nasdaq GlobeNewswire

Enochian BioSciences Announces a Scientific Presentation of Proof-of-Concept Studies for a Potential Therapy for Cancers with a Poor Life Expectancy by a Leading Researcher

29 Mar 2023 09:00:00 By Nasdaq GlobeNewswire

Enochian BioSciences Achieves Full Compliance with NASDAQ Filing Requirements

13 Mar 2023 08:30:00 By Nasdaq GlobeNewswire

Enochian BioSciences Announces Receipt of Notice from Nasdaq Regarding Delayed Filing of Form 10-Q for the Period Ended December 31, 2022

23 Feb 2023 16:04:00 By Nasdaq GlobeNewswire

Enochian BioSciences Announces Receipt of Notice from Nasdaq Regarding Delayed Filing of Form 10-Q for the Period Ended September 30, 2022

30 Nov 2022 17:20:12 By Nasdaq GlobeNewswire

Enochian BioSciences Forges Ahead With Focused Approach, Promising Future

24 Oct 2022 08:00:01 By Nasdaq GlobeNewswire

Enochian BioSciences Announces Receipt of Notice from Nasdaq Regarding Delayed Filing of Annual Report on Form 10-K

21 Oct 2022 17:00:00 By Nasdaq GlobeNewswire

Enochian BioSciences Awarded U.S. Patent For Its Promising Oncology Platform

17 Oct 2022 08:30:00 By Nasdaq GlobeNewswire

Enochian BioSciences Appoints Dr. Richard Whitley As Senior Scientific Advisor

25 Jul 2022 10:15:16 By Nasdaq GlobeNewswire

Enochian BioSciences Announces Findings From A Rigorous Internal Review of Scientific Data

01 Jul 2022 17:00:00 By Nasdaq GlobeNewswire

Scientific Leaders Agree on Promise of Enochian BioSciences

31 May 2022 08:00:00 By Nasdaq GlobeNewswire

Enochian BioSciences Board Learns of Arrest of Co-Founder and Inventor and Expresses Strong Confidence in the Promising Future of the Company

25 May 2022 16:20:30 By Nasdaq GlobeNewswire

Enochian BioSciences Announces the Appointment of Executive Vice President of Research and Development with 25 years of Industry Experience

20 Apr 2022 07:00:01 By Nasdaq GlobeNewswire

Enochian BioSciences Announces Appointment of Senior Vice President for Clinical Operations with 32 Years’ Experience at Pfizer

07 Apr 2022 06:00:00 By Nasdaq GlobeNewswire

Enochian BioSciences Inventor and Co-Founder Presents Data on Novel Clinical Approaches as the Invited, Concluding Plenary Speaker at the Innate Killer Summit

05 Apr 2022 06:00:00 By Nasdaq GlobeNewswire

Enochian BioSciences and Caring Cross Announce a Partnership to Potentially Increase the Effectiveness of a CAR-T Approach for HIV Cure Currently Being Studied in Humans

15 Mar 2022 07:00:01 By Nasdaq GlobeNewswire

Enochian BioSciences Announces Scientific Presentation at World Vaccine Conference on Promising Human and Laboratory Data to Potentially Treat Solid Tumors

03 Dec 2021 07:00:00 By Nasdaq GlobeNewswire

Enochian BioSciences Announces the Successful Completion of an FDA Pre-IND for a Potential Cure for HIV: The Second Pre-IND in 1 month

18 Oct 2021 07:00:01 By Nasdaq GlobeNewswire

Scientific Advisory Board Member Resigns Due to Conflict with Responsibilities with Important Public Sector Entity

15 Oct 2021 18:00:00 By Nasdaq GlobeNewswire